Inspyr Therapeutics, Inc.

Big changes were announced at Oculis : the Icelandic clinical-stage biotech named Riad Sherif chief executive officer, succeeding Páll Ragnar Jóhannesson who becomes chief financial officer and

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Two Un

CRISPR Therapeutics AG has promoted Samarth Kulkarni to CEO – effective Dec. 1, 2017. Kulkarni joined the company as chief business officer and most recently he was president of CRISPR Therapeut

The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between Dec. 30, 2016 and Jan. 5, 2017, di